v3.26.1
Fair Value Measurements (Tables)
 6 Months Ended
Jun. 30, 2026
Fair Value Disclosures [Abstract]  
Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis
The following tables present assets and liabilities that are measured at fair value on a recurring basis as of the dates presented:
 
Level 1Level 2Level 3Totals
June 30, 2026
Financial assets:
Securities available for sale$— $2,842,424 $— $2,842,424 
Derivative instruments— 24,621 — 24,621 
Mortgage loans held for sale in loans held for sale— 241,588 — 241,588 
Total financial assets$— $3,108,633 $— $3,108,633 
Financial liabilities:
Contingent consideration— — 6,327 6,327 
Derivative instruments:— 21,017 — 21,017 
Total financial liabilities$— $21,017 $6,327 $27,344 

Level 1Level 2Level 3Totals
December 31, 2025
Financial assets:
Securities available for sale$— $2,560,818 $— $2,560,818 
Derivative instruments— 47,098 — 47,098 
Mortgage loans held for sale in loans held for sale— 265,959 — 265,959 
Total financial assets$— $2,873,875 $— $2,873,875 
Financial liabilities:
Derivative instruments$— $41,484 $— $41,484 
Schedule of Significant Unobservable Inputs (Level 3) Used in Valuation of Liabilities Measured at Fair Value on Recurring Basis
The following table presents information as of June 30, 2026 about significant unobservable inputs (Level 3) used in the valuation of liabilities measured at fair value on a recurring basis:
Financial liabilityFair
Value		Valuation TechniqueSignificant
Unobservable Inputs		Inputs
Contingent consideration$6,327 
Discounted scenario-based probability-weighted cash flow
Probability of growth scenarios in factoring business
2% - 51% (range)
43% (weighted average)
Schedule of Assets Measured at Fair Value on a Nonrecurring Basis The following tables provide the fair value measurement for assets measured at fair value on a nonrecurring basis that were still held on the Consolidated Balance Sheets as of the dates presented and the level within the fair value hierarchy each is classified:
 
June 30, 2026Level 1Level 2Level 3Totals
Collateral dependent loans$— $— $26,712 $26,712 
OREO— — 702 702 
Total$— $— $27,414 $27,414 
 
December 31, 2025Level 1Level 2Level 3Totals
Collateral dependent loans$— $— $87,680 $87,680 
OREO— — $3,538 3,538 
Total$— $— $91,218 $91,218 
Schedule of OREO Measured at Fair Value on a Nonrecurring Basis
The following table presents, as of the dates presented, OREO measured at fair value on a nonrecurring basis that was still held on the Consolidated Balance Sheets at period-end:
June 30,
2026		December 31, 2025
Carrying amount prior to remeasurement$921 $4,182 
Impairment recognized in results of operations(219)(644)
Fair value$702 $3,538 
Significant Unobservable Inputs Used In Valuation Of Assets And Liabilities Measured At Fair Value On Non Recurring Basis
The following table presents information as of June 30, 2026 about significant unobservable inputs (Level 3) used in the valuation of assets measured at fair value on a nonrecurring basis:
Financial instrumentFair
Value		Valuation TechniqueSignificant
Unobservable Inputs		Inputs
Collateral dependent loans, net of allowance for credit losses$26,712 Appraised value of collateral less estimated costs to sellEstimated costs to sell
10%
OREO$702 Appraised value of property less estimated costs to sellEstimated costs to sell
 10%
Schedule of Differences Between Fair Value and Principal Balance for Mortgage Loans Held for Sale Measure at Fair Value
The following table summarizes the differences between the fair value and the principal balance for mortgage loans held for sale measured at fair value as of June 30, 2026 and December 31, 2025:
Aggregate
Fair Value		Aggregate
Unpaid
Principal
Balance		Difference
June 30, 2026
Mortgage loans held for sale measured at fair value$241,588 $237,639 $3,949 
December 31, 2025
Mortgage loans held for sale measured at fair value$265,959 $260,841 $5,118 
Schedule of Assets and Liabilities Not Measured and Reported at Fair Value on a Recurring Basis or Nonrecurring Basis
The carrying amounts and estimated fair values of the Company’s financial instruments, including those assets and liabilities that are not measured and reported at fair value on a recurring basis or nonrecurring basis, were as follows as of the dates presented:
 
Fair Value
As of June 30, 2026Carrying
Value		Level 1Level 2Level 3Total
Financial assets
Cash and cash equivalents$881,203 $881,203 $— $— $881,203 
Securities held to maturity983,032 — 902,853 — 902,853 
Securities available for sale2,842,424 — 2,842,424 — 2,842,424 
Loans held for sale241,588 — 241,588 — 241,588 
Loans, net18,900,164 — — 18,776,911 18,776,911 
Mortgage servicing rights65,816 — — 87,479 87,479 
Derivative instruments24,621 — 24,621 — 24,621 
Financial liabilities
Deposits$21,701,052 $21,690,697 $— $21,690,697 
Short-term borrowings315,225 — 315,225 — 315,225 
Junior subordinated debentures141,185 — 127,686 — 127,686 
Subordinated notes655,284 — 657,165 — 657,165 
Derivative instruments21,017 — 21,017 — 21,017 
Contingent consideration6,327 — — 6,327 6,327 
Fair Value
As of December 31, 2025Carrying
Value		Level 1Level 2Level 3Total
Financial assets
Cash and cash equivalents$1,070,718 $1,070,718 $— $— $1,070,718 
Securities held to maturity1,030,073 — 961,870 — 961,870 
Securities available for sale2,560,818 — 2,560,818 — 2,560,818 
Loans held for sale265,959 — 265,959 — 265,959 
Loans, net18,753,084 — — 18,689,957 18,689,957 
Mortgage servicing rights65,271 — — 80,537 80,537 
Derivative instruments47,098 — 47,098 — 47,098 
Financial liabilities
Deposits$21,473,070 $— $21,465,168 $— $21,465,168 
Short-term borrowings555,774 — 555,774 — 555,774 
Junior subordinated debentures140,632 — 126,976 — 126,976 
Subordinated notes359,124 — 352,616 — 352,616 
Derivative instruments41,484 — 41,484 — 41,484